On September 3, 2014, the FDA announced that there is little evidence that testosterone drugs, like AndroGel, are benficial. The FDA's announcement comes in advance of a September 17th meeting to discuss the risks and use of testosterone medications. Despite the pharmaceutical industry's successful creation of a disease called "Low-T," the FDA insists that "the need to replace testosterone in these older men remains debatable."
At the forthcoming hearing, the FDA will also discuss the risks of testosterone, including heart attacks, strokes, pulmonary emboli, blood clots and congestive heart failure.
If you or a loved one have suffered a heart attack, stroke, pulmonary embolism, blood clot or congestive heart failure after taking testosterone, please call one of our experienced AndroGel attorneys for a free consultation about your potential AndroGel lawsuit.